These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16386095)

  • 1. EXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulin.
    White S; Bennett DB; Cheu S; Conley PW; Guzek DB; Gray S; Howard J; Malcolmson R; Parker JM; Roberts P; Sadrzadeh N; Schumacher JD; Seshadri S; Sluggett GW; Stevenson CL; Harper NJ
    Diabetes Technol Ther; 2005 Dec; 7(6):896-906. PubMed ID: 16386095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design and performance of the exubera pulmonary insulin delivery system.
    Harper NJ; Gray S; De Groot J; Parker JM; Sadrzadeh N; Schuler C; Schumacher JD; Seshadri S; Smith AE; Steeno GS; Stevenson CL; Taniere R; Wang M; Bennett DB
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S16-27. PubMed ID: 17563300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.
    Drugs R D; 2004; 5(3):166-70. PubMed ID: 15139780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs.
    Miller DP; Tan T; Tarara TE; Nakamura J; Malcolmson RJ; Weers JG
    Mol Pharm; 2015 Aug; 12(8):2582-93. PubMed ID: 26052676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure insulin highly respirable powders for inhalation.
    Balducci AG; Cagnani S; Sonvico F; Rossi A; Barata P; Colombo G; Colombo P; Buttini F
    Eur J Pharm Sci; 2014 Jan; 51():110-7. PubMed ID: 23981336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition.
    Shen ZG; Chen WH; Jugade N; Gao LY; Glover W; Shen JY; Yun J; Chen JF
    Int J Pharm; 2012 Jul; 430(1-2):98-103. PubMed ID: 22486960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-micro- and nanoparticles for pulmonary delivery.
    Klingler C; Müller BW; Steckel H
    Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of capsule dosing techniques for use in dry powder inhalers.
    Edwards D
    Ther Deliv; 2010 Jul; 1(1):195-201. PubMed ID: 22816126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10.
    Kuehl PJ; Cherrington A; Dobry DE; Edgerton D; Friesen DT; Hobbs C; Leach CL; Murri B; Neal D; Lyon DK; Vodak DT; Reed MD
    AAPS PharmSciTech; 2014 Dec; 15(6):1545-50. PubMed ID: 25106135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality by design - Spray drying of insulin intended for inhalation.
    Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
    Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry.
    Huyge K; Van Reeth K; De Beer T; Landman WJ; van Eck JH; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Apr; 80(3):649-56. PubMed ID: 22155763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
    Zhu B; Young PM; Ong HX; Crapper J; Flodin C; Qiao EL; Phillips G; Traini D
    J Pharm Sci; 2015 Jul; 104(7):2169-76. PubMed ID: 25931324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled insulin: Exubera.
    Odegard PS; Capoccia KL
    Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation Design of Dry Powders for Inhalation.
    Weers JG; Miller DP
    J Pharm Sci; 2015 Oct; 104(10):3259-88. PubMed ID: 26296055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.